Ueda N et al. |
Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol. |
2011 Jan-Feb |
Biofactors |
pmid:21328621
|
Pascual AC et al. |
Aging modifies the enzymatic activities involved in 2-arachidonoylglycerol metabolism. |
2013 Mar-Apr |
Biofactors |
pmid:23281018
|
Sugiura T |
Physiological roles of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. |
2009 Jan-Feb |
Biofactors |
pmid:19319851
|
Gokoh M et al. |
2-Arachidonoylglycerol enhances the phagocytosis of opsonized zymosan by HL-60 cells differentiated into macrophage-like cells. |
2007 |
Biol. Pharm. Bull. |
pmid:17603153
|
Lu HC and Mackie K |
An Introduction to the Endogenous Cannabinoid System. |
2016 |
Biol. Psychiatry |
pmid:26698193
|
Bedse G et al. |
Functional Redundancy Between Canonical Endocannabinoid Signaling Systems in the Modulation of Anxiety. |
2017 |
Biol. Psychiatry |
pmid:28438413
|
Jenniches I and Zimmer A |
Reply to: The Anxiolytic Actions of 2-Arachidonoylglycerol: Converging Evidence From Two Recent Genetic Endocannabinoid Deficiency Models. |
2016 |
Biol. Psychiatry |
pmid:26410564
|
Patel S et al. |
The Anxiolytic Actions of 2-Arachidonoylglycerol: Converging Evidence From Two Recent Genetic Endocannabinoid Deficiency Models. |
2016 |
Biol. Psychiatry |
pmid:26212898
|
Saravia R et al. |
CB Cannabinoid Receptors Mediate Cognitive Deficits and Structural Plasticity Changes During Nicotine Withdrawal. |
2017 |
Biol. Psychiatry |
pmid:27737762
|
Busquets-Garcia A et al. |
Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses. |
2011 |
Biol. Psychiatry |
pmid:21684528
|
Volk DW and Lewis DA |
The Role of Endocannabinoid Signaling in Cortical Inhibitory Neuron Dysfunction in Schizophrenia. |
2016 |
Biol. Psychiatry |
pmid:26210060
|
Cobellis G et al. |
A gradient of 2-arachidonoylglycerol regulates mouse epididymal sperm cell start-up. |
2010 |
Biol. Reprod. |
pmid:19812302
|
Paria BC et al. |
Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors. |
1998 |
Biol. Reprod. |
pmid:9623610
|
Wang X et al. |
Circulating Endocannabinoids and Insulin Resistance in Patients with Obstructive Sleep Apnea. |
2016 |
Biomed Res Int |
pmid:26904688
|
Spaziano G et al. |
Exposure to Allergen Causes Changes in NTS Neural Activities after Intratracheal Capsaicin Application, in Endocannabinoid Levels and in the Glia Morphology of NTS. |
2015 |
Biomed Res Int |
pmid:25866824
|
Casida JE et al. |
S-Arachidonoyl-2-thioglycerol synthesis and use for fluorimetric and colorimetric assays of monoacylglycerol lipase. |
2010 |
Bioorg. Med. Chem. |
pmid:20138526
|
Parkkari T et al. |
Synthesis and CB1 receptor activities of dimethylheptyl derivatives of 2-arachidonoyl glycerol (2-AG) and 2-arachidonyl glyceryl ether (2-AGE). |
2006 |
Bioorg. Med. Chem. |
pmid:16403642
|
Suhara Y et al. |
Synthesis and biological evaluation of several structural analogs of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. |
2007 |
Bioorg. Med. Chem. |
pmid:17110113
|
Nomura DK et al. |
Monoacylglycerol lipase regulates 2-arachidonoylglycerol action and arachidonic acid levels. |
2008 |
Bioorg. Med. Chem. Lett. |
pmid:18752948
|
Vadivel SK et al. |
Conformationally constrained analogues of 2-arachidonoylglycerol. |
2007 |
Bioorg. Med. Chem. Lett. |
pmid:17826996
|
Hoover HS et al. |
Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling. |
2008 |
Bioorg. Med. Chem. Lett. |
pmid:18657971
|
Parkkari T et al. |
Alpha-methylated derivatives of 2-arachidonoyl glycerol: synthesis, CB1 receptor activity, and enzymatic stability. |
2006 |
Bioorg. Med. Chem. Lett. |
pmid:16466915
|
Suhara Y et al. |
Synthesis and biological activities of novel structural analogues of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. |
2001 |
Bioorg. Med. Chem. Lett. |
pmid:11454463
|
Janssen FJ and van der Stelt M |
Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders. |
2016 |
Bioorg. Med. Chem. Lett. |
pmid:27394666
|
Abed SM et al. |
Synthesis of 1,3-dioleoyl-2-arachidonoylglycerol-rich structured lipids by lipase-catalyzed acidolysis of microbial oil from Mortierella alpina. |
2017 |
Bioresour. Technol. |
pmid:28688328
|
Deng H and van der Stelt M |
Chemical tools to modulate 2-arachidonoylglycerol biosynthesis. |
2018 |
Biotechnol. Appl. Biochem. |
pmid:28589628
|
Psychoyos D et al. |
Cannabinoid receptor 1 signaling in embryo neurodevelopment. |
2012 |
Birth Defects Res. B Dev. Reprod. Toxicol. |
pmid:22311661
|
Jordà MA et al. |
Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol. |
2002 |
Blood |
pmid:11929767
|
Jordà MA et al. |
The peripheral cannabinoid receptor Cb2, a novel oncoprotein, induces a reversible block in neutrophilic differentiation. |
2003 |
Blood |
pmid:12406867
|
Alberich Jordà M et al. |
The peripheral cannabinoid receptor Cb2, frequently expressed on AML blasts, either induces a neutrophilic differentiation block or confers abnormal migration properties in a ligand-dependent manner. |
2004 |
Blood |
pmid:15039279
|
Soderstrom K et al. |
Cannabinoid exposure during zebra finch sensorimotor vocal learning persistently alters expression of endocannabinoid signaling elements and acute agonist responsiveness. |
2011 |
BMC Neurosci |
pmid:21211022
|
Cipriano M et al. |
The influence of monoacylglycerol lipase inhibition upon the expression of epidermal growth factor receptor in human PC-3 prostate cancer cells. |
2014 |
BMC Res Notes |
pmid:25012825
|
Valastro C et al. |
Characterization of endocannabinoids and related acylethanolamides in the synovial fluid of dogs with osteoarthritis: a pilot study. |
2017 |
BMC Vet. Res. |
pmid:29110674
|
Gesell FK et al. |
Alterations of endocannabinoids in cerebrospinal fluid of dogs with epileptic seizure disorder. |
2013 |
BMC Vet. Res. |
pmid:24370333
|
Keown OP et al. |
2-arachidonyl glycerol activates platelets via conversion to arachidonic acid and not by direct activation of cannabinoid receptors. |
2010 |
Br J Clin Pharmacol |
pmid:20653671
|
Morgan CJ et al. |
Cerebrospinal fluid anandamide levels, cannabis use and psychotic-like symptoms. |
2013 |
Br J Psychiatry |
pmid:23580381
|
Pei R et al. |
Low-fat yogurt consumption reduces biomarkers of chronic inflammation and inhibits markers of endotoxin exposure in healthy premenopausal women: a randomised controlled trial. |
2017 |
Br. J. Nutr. |
pmid:29179781
|
Bashashati M et al. |
Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation. |
2015 |
Br. J. Pharmacol. |
pmid:25684407
|
Kirkham TC et al. |
Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. |
2002 |
Br. J. Pharmacol. |
pmid:12055133
|
Ryberg E et al. |
The orphan receptor GPR55 is a novel cannabinoid receptor. |
2007 |
Br. J. Pharmacol. |
pmid:17876302
|
Straiker A et al. |
Differential signalling in human cannabinoid CB1 receptors and their splice variants in autaptic hippocampal neurones. |
2012 |
Br. J. Pharmacol. |
pmid:22014238
|
Woodhams SG et al. |
Spinal administration of the monoacylglycerol lipase inhibitor JZL184 produces robust inhibitory effects on nociceptive processing and the development of central sensitization in the rat. |
2012 |
Br. J. Pharmacol. |
pmid:22924700
|
Hillard CJ et al. |
Inhibition of 2-arachidonoylglycerol catabolism modulates vasoconstriction of rat middle cerebral artery by the thromboxane mimetic, U-46619. |
2007 |
Br. J. Pharmacol. |
pmid:17891162
|
Lau BK et al. |
Endocannabinoid modulation by FAAH and monoacylglycerol lipase within the analgesic circuitry of the periaqueductal grey. |
2014 |
Br. J. Pharmacol. |
pmid:25041240
|
Du H et al. |
Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ. |
2011 |
Br. J. Pharmacol. |
pmid:21501147
|
Rimmerman N et al. |
Compartmentalization of endocannabinoids into lipid rafts in a dorsal root ganglion cell line. |
2008 |
Br. J. Pharmacol. |
pmid:17965731
|
Hohmann AG |
Inhibitors of monoacylglycerol lipase as novel analgesics. |
2007 |
Br. J. Pharmacol. |
pmid:17293886
|
Chicca A et al. |
The antinociceptive triterpene β-amyrin inhibits 2-arachidonoylglycerol (2-AG) hydrolysis without directly targeting cannabinoid receptors. |
2012 |
Br. J. Pharmacol. |
pmid:22646533
|
Lépicier P et al. |
Endocannabinoids protect the rat isolated heart against ischaemia. |
2003 |
Br. J. Pharmacol. |
pmid:12813004
|
Ho WS and Randall MD |
Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol. |
2007 |
Br. J. Pharmacol. |
pmid:17245358
|
Whyte LS et al. |
Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitro. |
2012 |
Br. J. Pharmacol. |
pmid:21649637
|
Guindon J and Hohmann AG |
A physiological role for endocannabinoid-derived products of cyclooxygenase-2-mediated oxidative metabolism. |
2008 |
Br. J. Pharmacol. |
pmid:18297102
|
Hu SS et al. |
Prostaglandin E2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NFkappaB activity. |
2008 |
Br. J. Pharmacol. |
pmid:18297109
|
Howlett AC et al. |
Endocannabinoid tone versus constitutive activity of cannabinoid receptors. |
2011 |
Br. J. Pharmacol. |
pmid:21545414
|
Booker L et al. |
The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice. |
2012 |
Br. J. Pharmacol. |
pmid:21506952
|
Mukhopadhyay P et al. |
CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model. |
2010 |
Br. J. Pharmacol. |
pmid:20590569
|
Gutierrez-Lopez MD et al. |
Involvement of 2-arachidonoyl glycerol in the increased consumption of and preference for ethanol of mice treated with neurotoxic doses of methamphetamine. |
2010 |
Br. J. Pharmacol. |
pmid:20590579
|
Solinas M et al. |
The endocannabinoid system in brain reward processes. |
2008 |
Br. J. Pharmacol. |
pmid:18414385
|
Sticht MA et al. |
Inhibition of monoacylglycerol lipase attenuates vomiting in Suncus murinus and 2-arachidonoyl glycerol attenuates nausea in rats. |
2012 |
Br. J. Pharmacol. |
pmid:21470205
|
Kerr DM et al. |
The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action. |
2013 |
Br. J. Pharmacol. |
pmid:23043675
|
Liao HT et al. |
Capsaicin in the periaqueductal gray induces analgesia via metabotropic glutamate receptor-mediated endocannabinoid retrograde disinhibition. |
2011 |
Br. J. Pharmacol. |
pmid:21232043
|
De Petrocellis L et al. |
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. |
2011 |
Br. J. Pharmacol. |
pmid:21175579
|
Bisogno T et al. |
A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol with potential anti-obesity effects. |
2013 |
Br. J. Pharmacol. |
pmid:23072382
|
Guindon J et al. |
Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain. |
2011 |
Br. J. Pharmacol. |
pmid:21198549
|
Murataeva N et al. |
Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS. |
2014 |
Br. J. Pharmacol. |
pmid:24102242
|
Avraham Y et al. |
Capsaicin affects brain function in a model of hepatic encephalopathy associated with fulminant hepatic failure in mice. |
2009 |
Br. J. Pharmacol. |
pmid:19764982
|
Petrosino S et al. |
The anti-inflammatory mediator palmitoylethanolamide enhances the levels of 2-arachidonoyl-glycerol and potentiates its actions at TRPV1 cation channels. |
2016 |
Br. J. Pharmacol. |
pmid:25598150
|
Izzo AA et al. |
Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding. |
2009 |
Br. J. Pharmacol. |
pmid:19371345
|
Savinainen JR et al. |
Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes. |
2001 |
Br. J. Pharmacol. |
pmid:11588122
|
Ghafouri N et al. |
Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol. |
2004 |
Br. J. Pharmacol. |
pmid:15492019
|
Guindon J et al. |
The antinociceptive effects of intraplantar injections of 2-arachidonoyl glycerol are mediated by cannabinoid CB2 receptors. |
2007 |
Br. J. Pharmacol. |
pmid:17179944
|
Ho WS et al. |
Role of endothelial TRPV4 channels in vascular actions of the endocannabinoid, 2-arachidonoylglycerol. |
2015 |
Br. J. Pharmacol. |
pmid:26294342
|
Soria-Gómez E et al. |
Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus. |
2007 |
Br. J. Pharmacol. |
pmid:17549045
|
Ho WS et al. |
Endocannabinoid modulation of hyperaemia evoked by physiologically relevant stimuli in the rat primary somatosensory cortex. |
2010 |
Br. J. Pharmacol. |
pmid:20590576
|
Centonze D et al. |
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. |
2007 |
Brain |
pmid:17626034
|
Mulder J et al. |
Molecular reorganization of endocannabinoid signalling in Alzheimer's disease. |
2011 |
Brain |
pmid:21459826
|
Doenni VM et al. |
Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling. |
2016 |
Brain Behav. Immun. |
pmid:27453335
|
Mecha M et al. |
Endocannabinoids drive the acquisition of an alternative phenotype in microglia. |
2015 |
Brain Behav. Immun. |
pmid:26086345
|
González S et al. |
Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine. |
2002 |
Brain Res. |
pmid:12393235
|
Hanus L et al. |
Short-term fasting and prolonged semistarvation have opposite effects on 2-AG levels in mouse brain. |
2003 |
Brain Res. |
pmid:12914975
|
Avraham Y et al. |
2-Arachidonoylglycerol as a possible treatment for anorexia nervosa in animal model in mice. |
2017 |
Brain Res. |
pmid:28606779
|
Soni N et al. |
Anandamide and 2-AG are endogenously present within the laterodorsal tegmental nucleus: Functional implications for a role of eCBs in arousal. |
2017 |
Brain Res. |
pmid:28404451
|
Lara-Celador I et al. |
Endocannabinoids reduce cerebral damage after hypoxic-ischemic injury in perinatal rats. |
2012 |
Brain Res. |
pmid:22841538
|
Hoot MR et al. |
Chronic constriction injury reduces cannabinoid receptor 1 activity in the rostral anterior cingulate cortex of mice. |
2010 |
Brain Res. |
pmid:20380816
|
Lourbopoulos A et al. |
Administration of 2-arachidonoylglycerol ameliorates both acute and chronic experimental autoimmune encephalomyelitis. |
2011 |
Brain Res. |
pmid:21406188
|
Yamaguchi T et al. |
Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice. |
2001 |
Brain Res. |
pmid:11478928
|
Parker KE et al. |
Effects of co-administration of 2-arachidonylglycerol (2-AG) and a selective µ-opioid receptor agonist into the nucleus accumbens on high-fat feeding behaviors in the rat. |
2015 |
Brain Res. |
pmid:26100333
|
Golech SA et al. |
Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors. |
2004 |
Brain Res. Mol. Brain Res. |
pmid:15548432
|
Romero J et al. |
Fatty acid amide hydrolase localization in the human central nervous system: an immunohistochemical study. |
2002 |
Brain Res. Mol. Brain Res. |
pmid:12008024
|
Scutt A and Williamson EM |
Cannabinoids stimulate fibroblastic colony formation by bone marrow cells indirectly via CB2 receptors. |
2007 |
Calcif. Tissue Int. |
pmid:17205329
|
Nithipatikom K et al. |
2-arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion. |
2004 |
Cancer Res. |
pmid:15604240
|
Mukhopadhyay S and Tulis DA |
Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke. |
2007 |
Cardiovasc Hematol Agents Med Chem |
pmid:17979695
|
Stanke-Labesque F et al. |
2-Arachidonoyl glycerol induces contraction of isolated rat aorta: role of cyclooxygenase-derived products. |
2004 |
Cardiovasc. Res. |
pmid:15194472
|
Jiang LS et al. |
Role of activated endocannabinoid system in regulation of cellular cholesterol metabolism in macrophages. |
2009 |
Cardiovasc. Res. |
pmid:19074161
|
Anderson GR et al. |
β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling. |
2015 |
Cell |
pmid:26213384
|
Tsumura M et al. |
TRPV1-mediated calcium signal couples with cannabinoid receptors and sodium-calcium exchangers in rat odontoblasts. |
2012 |
Cell Calcium |
pmid:22656960
|
Juan-Picó P et al. |
Cannabinoid receptors regulate Ca(2+) signals and insulin secretion in pancreatic beta-cell. |
2006 |
Cell Calcium |
pmid:16321437
|
Gasperi V et al. |
2-Arachidonoylglycerol enhances platelet formation from human megakaryoblasts. |
2014 |
Cell Cycle |
pmid:25427281
|
Valdeolivas S et al. |
The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG. |
2013 |
Cell Death Dis |
pmid:24136226
|
Friedman SL and Nieto N |
Cannabinoids provoke alcoholic steatosis through a conspiracy of neighbors. |
2008 |
Cell Metab. |
pmid:18316020
|